132 related articles for article (PubMed ID: 21258251)
1. Variation in comorbidity and clinical management in patients newly diagnosed with lung cancer in four Scottish centers.
Grose D; Devereux G; Brown L; Jones R; Sharma D; Selby C; Morrison DS; Docherty K; McIntosh D; Louden G; Downer P; Nicolson M; Milroy R;
J Thorac Oncol; 2011 Mar; 6(3):500-9. PubMed ID: 21258251
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Louden G; Nicolson M; McMillan DC; Milroy R;
Postgrad Med J; 2014 Jun; 90(1064):305-10. PubMed ID: 24676985
[TBL] [Abstract][Full Text] [Related]
3. The impact of comorbidity upon determinants of outcome in patients with lung cancer.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Nicolson M; McMillan DC; Milroy R;
Lung Cancer; 2015 Feb; 87(2):186-92. PubMed ID: 25498829
[TBL] [Abstract][Full Text] [Related]
4. Why do some lung cancer patients receive no anticancer treatment?
Vinod SK; Sidhom MA; Gabriel GS; Lee MT; Delaney GP
J Thorac Oncol; 2010 Jul; 5(7):1025-32. PubMed ID: 20453689
[TBL] [Abstract][Full Text] [Related]
5. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?
Erridge SC; Murray B; Williams L; Brewster D; Black R; Price A; Murray N; Sheehan F
Lung Cancer; 2009 Jun; 64(3):358-66. PubMed ID: 19036470
[TBL] [Abstract][Full Text] [Related]
6. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
[TBL] [Abstract][Full Text] [Related]
8. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study.
de Rijke JM; Schouten LJ; ten Velde GP; Wanders SL; Bollen EC; Lalisang RI; van Dijck JA; Kramer GW; van den Brandt PA
Lung Cancer; 2004 Nov; 46(2):233-45. PubMed ID: 15474672
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
[TBL] [Abstract][Full Text] [Related]
10. Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function.
Garzon JC; Ng CS; Sihoe AD; Manlulu AV; Wong RH; Lee TW; Yim AP
Ann Thorac Surg; 2006 Jun; 81(6):1996-2003. PubMed ID: 16731119
[TBL] [Abstract][Full Text] [Related]
11. Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.
Decoster L; Kenis C; Schallier D; Vansteenkiste J; Nackaerts K; Vanacker L; Vandewalle N; Flamaing J; Lobelle JP; Milisen K; De Grève J; Wildiers H
Lung; 2017 Oct; 195(5):619-626. PubMed ID: 28634893
[TBL] [Abstract][Full Text] [Related]
12. Causes and consequences of deviation from multidisciplinary care in thoracic oncology.
Osarogiagbon RU; Phelps G; McFarlane J; Bankole O
J Thorac Oncol; 2011 Mar; 6(3):510-6. PubMed ID: 21258245
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
[TBL] [Abstract][Full Text] [Related]
14. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
[TBL] [Abstract][Full Text] [Related]
15. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients.
Cheung MC; Hamilton K; Sherman R; Byrne MM; Nguyen DM; Franceschi D; Koniaris LG
Ann Surg Oncol; 2009 Jan; 16(1):3-13. PubMed ID: 18600379
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in lung cancer: important but neglected. a review of the current literature.
Grose D; Devereux G; Milroy R
Clin Lung Cancer; 2011 Jul; 12(4):207-11. PubMed ID: 21726818
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer. An analysis of the staging project database of the International Association for the Study of Lung Cancer.
Ball D; Mitchell A; Giroux D; Rami-Porta R;
J Thorac Oncol; 2013 Mar; 8(3):315-21. PubMed ID: 23334092
[TBL] [Abstract][Full Text] [Related]
18. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.
Mellemgaard A; Lüchtenborg M; Iachina M; Jakobsen E; Green A; Krasnik M; Møller H
J Thorac Oncol; 2015 Feb; 10(2):272-9. PubMed ID: 25371078
[TBL] [Abstract][Full Text] [Related]
19. Improved treatment and survival for lung cancer patients in South-East Scotland.
Erridge SC; Murray B; Price A; Ironside J; Little F; Mackean M; Walker W; Brewster DH; Black R; Fergusson RJ;
J Thorac Oncol; 2008 May; 3(5):491-8. PubMed ID: 18449001
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
